ADGC Publications

Found 192 results
2010
Li G, Shofer JB, Rhew IC, Kukull WA, Peskind ER, McCormick W, Bowen JD, Schellenberg GD, Crane PK, Breitner JCS et al..  2010.  Age-varying association between statin use and incident Alzheimer's disease.. J Am Geriatr Soc. 58(7):1311-7.
Koelle DM, Magaret A, Warren T, Schellenberg GD, Wald A.  2010.  APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding.. Sex Transm Infect. 86(3):202-6.
Bekris LM, Galloway NM, Montine TJ, Schellenberg GD, Yu C-E.  2010.  APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure.. Am J Med Genet B Neuropsychiatr Genet. 153B(2):409-417.
Van Deerlin VM, Sleiman PMA, Martinez-Lage M, Chen-Plotkin A, San Wang L-, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M et al..  2010.  Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.. Nat Genet. 42(3):234-9.
Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES et al..  2010.  A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.. Neurology. 75(13):1189-94.
Borenstein AR, Mortimer JA, Schellenberg GD, DeCarli C, Copenhaver C, Galasko D, Salmon DP, Petersen R.  2010.  Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P.. Am J Alzheimers Dis Other Demen. 25(3):233-8.
Marchani EE, Bird TD, Steinbart EJ, Rosenthal E, Yu C-E, Schellenberg GD, Wijsman EM.  2010.  Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families.. Am J Med Genet B Neuropsychiatr Genet. 153B(5):1031-41.
Han M-R, Schellenberg GD, San Wang L-.  2010.  Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.. BMC Neurol. 10:90.
Melrose HL, Dächsel JC, Behrouz B, Lincoln SJ, Yue M, Hinkle KM, Kent CB, Korvatska E, Taylor JP, Witten L et al..  2010.  Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.. Neurobiol Dis. 40(3):503-17.
Kraemer BC, Schuck T, Wheeler JM, Robinson LC, Trojanowski JQ, M Y Lee V, Schellenberg GD.  2010.  Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis.. Acta Neuropathol. 119(4):409-19.
Jun G, Naj AC, Beecham GW, Wang L-S, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, M Fallin D, Friedland R et al..  2010.  Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.. Arch Neurol. 67(12):1473-84.
Shen L, Qi Y, Kim S, Nho K, Wan J, Risacher SL, Saykin AJ.  2010.  Sparse bayesian learning for identifying imaging biomarkers in AD prediction.. Med Image Comput Comput Assist Interv. 13(Pt 3):611-8.
VanFossen BT, G Watson S, Baker LD, Rhoads KW, Cholerton BA, Reger MA, Plymate SR, Schellenberg G, Craft S.  2010.  Statin users without an APOE-epsilon4 allele have increased insulin resistance.. J Alzheimers Dis. 19(4):1149-53.

Pages